ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS SECRETS

RUNX1 is usually a learn transcription aspect that regulates the expression of many genes needed for hematopoiesis. Studies implied the RUNX1- "Our study uncovered the vital part from the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 or ABBV-7